GENE ONLINE|News &
Opinion
Blog

2021-11-15|

9 Leading Molecular Diagnostics Companies to Watch in Taiwan

by Joy Lin
Share To
Molecular diagnosis is a pillar of precision medicine. Capable of predicting treatment effects through a comprehensive analysis of the patient's condition, the approach allows optimal drug selection to slash time and cost for recovery.

Furthermore, periodic screening for biomarkers could detect disease in the early stages, giving much-needed time for prompt treatment that could improve the survival rate of patients. And more importantly, accurate screening helps clinical drug development. These advantages prove how important molecular diagnostics are to modern society.

Taiwan is highly active in the area of in-vitro diagnostics research and development, having launched numerous tests for the world's most popular diseases. In this article, we list 9 companies that will give a quick snapshot of the island's molecular diagnostics industry.

GO Prime with only $1.49 now

LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!